A detailed history of Wellington Management Group LLP transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 294,133 shares of TNYA stock, worth $491,202. This represents 0.0% of its overall portfolio holdings.

Number of Shares
294,133
Previous 216,898 35.61%
Holding current value
$491,202
Previous $672,000 15.63%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.93 - $3.99 $149,063 - $308,167
77,235 Added 35.61%
294,133 $567,000
Q2 2024

Aug 13, 2024

BUY
$2.72 - $4.99 $64,401 - $118,148
23,677 Added 12.25%
216,898 $672,000
Q1 2024

May 15, 2024

BUY
$2.88 - $6.8 $556,476 - $1.31 Million
193,221 New
193,221 $1.01 Million
Q3 2023

Nov 14, 2023

BUY
$2.55 - $5.65 $185,451 - $410,901
72,726 Added 62.68%
188,751 $481,000
Q2 2023

Aug 14, 2023

BUY
$2.64 - $7.64 $306,306 - $886,431
116,025 New
116,025 $681,000

Others Institutions Holding TNYA

About Tenaya Therapeutics, Inc.


  • Ticker TNYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,364,700
  • Market Cap $69.1M
  • Description
  • Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...
More about TNYA
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.